AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Concordance and Acceptability of Self-screening Versus Screening by a Healthcare Professional for HPV, a Risk Factor for Anal Cancer, by Swab in People Living With HIV

RecruitingNAAges 30 Years - anyAllCentre Hospitalier Universitaire de la Réunion
💬

In plain words

What the trial is, and whether it could suit you

Anal canal cancers are on the increase in France, with around 2,000 new cases per year. These lesions can be detected by directed biopsies or smear tests. The incidence rate of anal cancer is 30 times higher in people living with HIV than in the general population. According to a recent study, the risk of anal cancer is highest in this population, but is also high in heterosexual men over 30 and women over 30. However, the proposal of a proctological examination in this population is not systematic. In France, there is no HPV screening for people living with HIV, but there is a recommendation for proctology consultation in certain cases, notably for men who have sex with men (MSM) or for women with vaginal cervical lesions. Several oncogenic HPV serotypes have been identified in the genesis of anal cancer. The serotype identified as the most carcinogenic is HPV-16 (89%). This study

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: Patient : * living with HIV * aged 30 or over * resident on Reunion island and followed at the University Hospital of Reunion Island (the only follow-up center on the island) * Able to perform anal self-sampling * Able to answer a questionnaire * Affiliated with or benefiting from a social security scheme * Have given free, informed and signed consent Exclusion Criteria: * People with a previous anal swab less than 7 days old * Persons with a known current diagnosis of anal cancer * Persons deprived of liberty by judicial or administrative decision, minors, and persons under legal protection: guardianship or curators
💊

What it tests

  • anal swabbing
📍

Where

2 sites
CHU de la Réunion Recherche Clinique
Saint-Denis, Reunion
CHU de la Réunion Recherche Clinique
Saint-Pierre, Reunion
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy